Previous Article | Next Article ![]()
Molecular and Cellular Biology, October 2006, p. 7283-7298, Vol. 26, No. 19
0270-7306/06/$08.00+0 doi:10.1128/MCB.00510-06
Copyright © 2006, American Society for Microbiology. All Rights Reserved.
B/Rel Regulates Inhibitory and Excitatory Neuronal Function and Synaptic Plasticity
Jacob Raber,3,4,5,
Mauricio Montano,1,
Erik Foehr,1,
,
Victor Han,5
Shao-ming Lu,6
Hakju Kwon,1,
Anthony LeFevour,3
Shikha Chakraborty-Sett,7 and
Warner C. Greene1,2*
Gladstone Institute of Virology and Immunology,1 Departments of Medicine and Microbiology and Immunology, University of California, San Francisco, California 94141,2 Departments of Behavioral Neuroscience,3 Neurology,4 Division of Neuroscience, Oregon National Primate Research Center, Oregon Health and Science University, Portland, Oregon 97239,5 Department of Neurology, Center for Aging and Developmental Biology,6 Department of Microbiology and Immunology, University of Rochester Medical Center, Rochester, New York 146427
Received 22 March 2006/ Returned for modification 20 April 2006/ Accepted 13 July 2006
| ABSTRACT |
|---|
|
|
|---|
B/Rel to these processes, we generated transgenic mice
conditionally expressing a potent NF-
B/Rel inhibitor termed
I
B
superrepressor (I
B
-SR). Using
the prion promoter-enhancer, I
B
-SR is robustly
expressed in inhibitory GABAergic interneurons and, at lower levels, in
excitatory neurons but not in glia. This neuronal pattern of
I
B
-SR expression leads to decreased expression of
glutamate decarboxylase 65 (GAD65), the enzyme required for synthesis
of the major inhibitory neurotransmitter,
-aminobutyric acid
(GABA) in GABAergic interneurons. I
B
-SR expression
also results in diminished basal GluR1 levels and impaired synaptic
strength (input/output function), both of which are fully restored
following activity-based task learning. Consistent with diminished
GAD65-derived inhibitory tone and enhanced excitatory firing,
I
B
-SR+ mice exhibit increased
late-phase long-term potentiation, hyperactivity, seizures, increased
exploratory activity, and enhanced spatial learning and memory.
I
B
-SR+ neurons also express higher
levels of the activity-regulated,
cytoskeleton-associated (Arc) protein, consistent with
neuronal hyperexcitability. These findings suggest that
NF-
B/Rel transcription factors act as pivotal regulators of
activity-dependent inhibitory and excitatory neuronal function
regulating synaptic plasticity and
memory. | INTRODUCTION |
|---|
|
|
|---|
-aminobutyric
acid) interneurons, respectively
(47,
54). While the vast
majority of studies to date have focused on the cyclic AMP-responsive
transcription factor (CREB) regulating excitatory neuron function
(7,
32-34,
62,
72), more recently, other
transcription factors, including members of the NF-
B/Rel
family of transcription factors, have been implicated in
experience-based synaptic adaptations
(38,
45,
49,
55). However,
our understanding of their precise role in regulating
synaptic plasticity remains rudimentary at best.
Although
NF-
B/Rel factors were originally implicated as central
regulators of the immune and inflammatory responses, both basal
expression and stimulus-coupled induction of NF-
B/Rel factors
occur in neurons and glial cells
(23,
30,
31,
45,
48,
55).Activation of NF-
B/Rel proceeds through the site-specific
phosphorylation, polyubiquitylation, and proteasome-mediated
degradation of the major NF-
B/Rel inhibitor protein,
I
B
(41). The newly liberated
NF-
B/Rel complex rapidly translocates into the nucleus, where
it engages cognate
B enhancer elements in a variety of
cellular target genes including the I
B
gene eliciting
an auto-inhibitory feedback loop
(65). Substitution of the
two key serine phospho-acceptor sites in I
B
with
alanines (S32A/S36A) generates a potent, nondegradable inhibitor of
NF-
B/Rel activation termed the I
B
superrepressor (I
B
-SR)
(6,
61,
74), which serves as a
useful tool to probe NF-
B action in vivo
(40,
71).
As
transcriptional regulators, NF-
B/Rel proteins can potentially
either positively or negatively regulate the expression of genes
governing changes in synaptic plasticity and cognitive functions
(73). Several reports
support a positive link between the activation of NF-
B/Rel
factors and the induction of long-term potentiation (LTP) or long-term
depression, experimental correlates of learning and memory
(1,
17,
20,
48). Observations in the
crab also support a positive role for NF-
B/Rel action in
emotional learning and fear responses
(16,
50). Similarly, mice
lacking the p50 subunit of NF-
B/Rel display impaired emotional
learning and decreased anxiety-related responses but exhibit increased
exploratory activity (37,
38). In contrast, other
studies suggest a negative correlation between NF-
B action and
synaptic function. For example, NF-
B/Rel activation has also
been shown to impair the generation of synaptic currents in hippocampal
neurons (20). Increased
NF-
B/Rel action is also associated with the accelerated onset
of cognitive deficits in an experimental model of Alzheimer's disease
(2).
These
apparently conflicting observations could reflect distinct roles for
the various NF-
B/Rel factors in regulating different cognitive
behaviors in select brain regions. Alternatively, these different
outcomes may involve specific NF-
B/Rel actions in distinct
neuronal subtypes and/or in glia. In support of the latter, Meffert et
al. have reported that loss of the RelA/p65 subunit of NF-
B,
in the context of concomitant tumor necrosis factor receptor 1 (TNFR1)
deficiency, in both neuronal and glial cells results in impaired
spatial learning and memory
(49). Additionally,
Fridmacher et al. and Kaltschmidt et al.
(19,
29), using the CamKII
promoter to direct expression of the NF-
B/Rel inhibitor
exclusively in excitatory neurons of the forebrain, have demonstrated a
clear positive requirement for NF-
B/Rel action in regulating
synaptic plasticity and memory. To date the potential function of
NF-
B/Rel in inhibitory GABAergic interneurons remains
unexplored (47).
In
our present study, we have utilized the prion promoter and enhancer
(70) to direct the
expression in neurons of a potent, nondegradable inhibitor of
NF-
B/Rel activation, termed the I
B
superrepressor. I
B
-SR+ mice
display robust I
B
-SR expression in inhibitory
interneurons, somewhat lower levels of expression in excitatory
neurons, and no detectable expression in glia. These
I
B
-SR animals were used to explore the role of
NF-
B/Rel in various electrophysiological and biochemical
parameters in the brain. Our findings reveal that pan-neuronal
inhibition of NF-
B action results in a marked enhancement of
activity-dependent synaptic signaling and select cognitive functions
including learning and memory.
| MATERIALS AND METHODS |
|---|
|
|
|---|
B
-SR bigenic mice.
A total of eight transgenic
pTet-O-HA-I
B
-SR founder lines were generated by
pronuclear injection of linearized DNA into DBA inbred zygotes, and the
resulting mice were screened by PCR to detect the presence of the
transgene. Positive transgenic mice were crossed with FVBN mice
carrying a Prp/TtA transgene (Tet-off). Bigenic mice were screened by
PCR for both transgenes. At 1 month of age, FVBN/DBA bigenic litters
were divided into two groups and maintained on either a standard or a
doxycycline-supplemented diet. At 4 to 6 months of age, mice were
anesthetized with isoflurane and sacrificed by cervical dislocation.
Brains from control and I
B
-SR+
mice were removed, fixed in 4% paraformaldehyde, embedded in paraffin,
sectioned, and stained with Nissl stain for histological examination.
Strict adherence to institutional and NIH guidelines was maintained in
all procedures relating to the care and treatment of mice. As discussed
in the results section, three independently derived transgenic lines,
demonstrating readily detectable I
B
-SR transgene in
the absence of doxycycline but near complete inhibition of
I
B
-SR expression in the presence of doxycycline, were
selected for further study. Use of three independently derived founder
lines minimized effects related to the site of transgene
integration. Immunoprecipitation, immunoblotting, and immunofluorescence. Mice from each group were anesthetized with isoflurane, perfused with saline followed by 4% paraformaldehyde, at 4 to 8 months of age. Brains were removed, and lysates from whole tissue or specific regions were prepared with a low-stringency buffer containing 50 mM Tris-HCl, pH 8, 120 mM NaCl, 5 mM EDTA, 0.5% (wt/vol) NP-40, supplemented with fresh 1x protease inhibitor cocktail (Calbiochem). Membrane-enriched fractions were isolated as described in Pharmingen protocols online. Lysates were either resolved by sodium dodecyl sulfate-polyacrylamide gel electrophoresis directly or were first immunoprecipitated with hemagglutinin (HA)-specific monoclonal antibodies (262K at a dilution of 1:200; Cell Signaling) conjugated to protein G agarose (25 µl of packed beads). Membranes were immunoblotted with HA-specific polyclonal antibodies (Y11 at a dilution of 1:1,00; Santa Cruz Biotechnology) and the antibodies indicated in the legends overnight at 4°C and visualized by chemiluminescence. For immunohistochemical and immunofluorescence analysis, brains were removed from selected mice following anesthetization with isoflurane and perfusion with saline and 4% paraformaldehyde and embedded in cryo-matrix mounting medium (22-oxyacalcitriol [OCT]; Tissue-Tek), frozen, and cryosectioned into 10-µm sections. Additionally, primary neuronal cultures (hippocampal or cortical) were grown on treated slides and probed. Frozen sections or slides were fixed in 4% paraformaldehyde and permeabilized in 0.2% Triton X-100. Sections were either stained with Nissl or incubated with primary antibodies (indicated in the legend) overnight at 4°C and probed with specific antibodies as outlined in the legends, followed with fluorescein isothiocyanate-conjugated or Alexa-conjugated secondary antibodies (1:1,000) for 60 min at room temperature. Sections were counter-stained with DAPI (4',6'-diamidino-2-phenylindole; 1:500) for 5 min for nuclear staining. Sections were mounted in Gel/Mount (Biomeda) and visualized under UV light on a Nikon E600 microscope connected to a SPOT advanced software camera. Several fields were compared for intensity of positive immunostaining by a technician blinded to the genotypes.
Evaluation of NF-
B/Rel signaling by electrophoretic mobility shift assay (EMSA) and RPA.
Bigenic
I
B
-SR+ and
I
B
-SR mice were treated with
kainic acid (KA) (22 mg/kg) by intraperitoneal injection at 4 to 6
months of age (44). Mice
were anesthetized, and hearts were perfused with saline at 7 to
8 h after KA injection. Brains were removed and lysed in
nuclear extraction buffer (20 mM Tris-HCl, pH 7.8, 125 mM NaCl, 5 mM
MgCl2, 0.2 mM EDTA, 12% [wt/vol] glycerol, and
0.1% [wt/vol] NP-40) supplemented with 10 µg/ml aprotinin, 1 mM
phenylmethylsulfonyl difluoride, and 1 mM dithiothreitol.Samples with matched protein concentrations were incubated with a
B/Rel enhancer probe radiolabeled with
[32
-P]ATP. Nucleoprotein-
B/Rel
complexes were separated on nondenaturing gels and visualized by
autoradiography. Control and bigenic mice were treated with KA as
described above. After 8 h, brains were removed, and total
RNA was isolated with an RNA isolation kit (Access RT PCR system;
Promega) according to the manufacturer's directions. An RNase
protection assay (RPA) was performed using the Riboquant system
(Pharmingen), and NF-
B-targeted RNA sequences were detected
with a specific probe template set
(mAPO-3).
Establishing primary neuronal cultures.
Embryonic day 15
embryos were removed from gestating mice and placed in ice-cold
1x Hanks balanced salt solution. Whole brains from these
embryos were rapidly removed, and the hippocampal formation and cortex
were isolated and washed in ice-cold 1x Hanks balanced salt
solution. The tissue was dissociated with papain using a Worthington
papain dissociation system, and isolated cells were plated at a
concentration of 4 x 104 cells/ml on
poly-L-lysine-coated six-well plates in neurobasal medium
supplemented with B-27. Cortical cultures enriched in GABAergic neurons
(>95%) were grown in the presence of valine (25 µg/ml),
pyruvate (2 mM), and
-ketoglutarate (5 mM) and in the absence
of glutamine. Hippocampal cultures enriched in glutamatergic neurons
(>87%) were maintained in medium supplemented with 2 mM
glutamine as described previously
(76). Cultures were
incubated at 37°C in a humidified atmosphere containing 5%
CO2. On day 3 the medium was changed and supplemented with
conditioned culture medium and mitotic inhibitor solution
(5-fluoro-2-deoxyuridine, cytosine-D-arabinofuranoside, and
uridine). Fresh medium was added every 24 h. On day 6,
cultures were incubated with fresh medium without glutamic acid and
maintained for up to 2 weeks. In experiments using enriched glial
cultures, cultures were shifted into Dulbecco's modified Eagle's
medium/F12 L-valine lacking KCl but supplemented
with 10% fetal calf serum, G5 (Gibco), and penicillin/streptomycin to
induce neuronal cell death.
Establishing postmitotic (adult) brain neurons and glial cells from the hippocampus. Hippocampal regions were rapidly dissected from the brains of postnatal day 1 (PN1) mice in 2 ml of Hibernate-A, supplemented with B27 and 0.5 mM L-glutamine. Meninges and excess white matter were removed. The hippocampus was sliced perpendicularly to the long axis and transferred to a tube containing fresh Hibernate-A/B27 and 0.5 mM L-glutamine and rocked at 30°C for 30 min. The slices were transferred to fresh Hibernate-A with papain (20 U/mg) and rocked at 30°C for 45 min. Slices were transferred to fresh Hibernate-A/B27 incubated at room temperature for 5 min. Slices were pipetted 15 times, and the pieces were allowed to settle for 2 min. The supernatant (cell suspension) was removed and carefully applied to the top of a gradient (35%, 25%, 20%, and 15%) formed with OptiPrep in Hibernate-A/B27 medium and centrifuged at 800 x g for 15 min. The top 6 ml (debris) was discarded. The underlying 2 ml, designated fraction 1, was enriched for oligodendrocytes. The next layer, fraction 2, contained neurons with accessory glia cells. Fraction 3 was enriched for neurons, and the pellet, fraction 4, was enriched for microglia. Each fraction was pelleted at 200 x g for 1 min and then resuspended in Neurobasal-A/B27 with L-glutamine and 1x gentamicin. Neurons were plated at 90 to 320 cells/mm2 on poly-D-lysine-coated plates in fresh Neurobasal-A/B27 medium supplemented with 0.5 mM L-glutamine, 10 µg/ml gentamicin, and 5 ng/ml fibroblast growth factor-ß.Glial cells from each representative fraction (oligodendrocytes, microglia, and mixed glial fraction), were resuspended at a concentration of 3 x 106 cells in 12 ml of MEM10 containing 1% penicillin/streptomycin, and 2 ml of each suspension was added to each well of a six-well plate precoated with poly-D-lysine. All cultures were maintained in a highly humidified atmosphere containing 5% CO2 at 37°C.
Reverse transcription-PCR analysis of GAD65 mRNA levels. Whole hippocampus from either untrained or trained (subjected to maze testing) mice in each genotypic group was collected for RNA quantification. RNA was extracted using an RNAeasy kit from QIAGEN. The purified RNA was DNase treated (Ambion, Austin, TX) and reverse transcribed from mRNA to cDNA using a first-strand synthesis kit (Invitrogen, Carlsbad, CA). The amount of cDNA was quantified using real-time PCR and primers sets designed to amplify GAD65. Glyceraldehyde-3-phosphate dehydrogenase (GAPDH) and ß-actin mRNA levels were used as internal controls for normalization. Amplified mRNA transcripts were visualized on 1.5% agarose gels.
Characterization of I
B
-SR bigenic mice.
At 1 month of age, bigenic
littermates were screened by PCR to confirm the presence of the
transgene, divided into two groups, and maintained on a normal or
doxycycline-supplemented diet. At 4 to 8 months, male mice from three
independently derived founder lines were selected for further analysis.
Progeny from each founder line behaved similarly in each of the various
assays.
Electrophysiological analysis. (i) Slice preparation. The animals were first anesthetized with halothane, and brains were rapidly removed and cooled in ice-cold artificial cerebrospinal fluid (ACSF) containing the following: 125 mM NaCl, 5 mM KCl, 1.25 mM NaH2PO4, 25 mM NaHCO3, 25 mM D-glucose, 2 mM CaCl2, 1 mM MgSO4, 0.01 mM glycine, and 1 mM kynurenic acid bubbled with a mixture gas of 95% O2 and 5% CO2. For slicing, 1 mM kynurenic acid was also added to ACSF. The solution pH was adjusted to 7.3 to 7.4, and osmolarity was set at 300 ± 10. The hippocampus was dissected, and 350-µm slices were cut transversely. A cut was routinely made between the CA1 and CA3 area right after slicing, and in some recordings, both CaCl2 and MgSO4 concentration was increased to 4 mM to reduce seizure-like activity and population spikes. All slices were collected in a holding chamber in the same solution maintained at 31 ± 1°C. A single slice was transferred to an interface recording chamber that was constantly perfused with the gas-saturated ACSF at 1 ml/min at 29 ± 1°C. The recording chamber was also constantly superfused with gas-saturated moist air during recording. The remaining slices were kept in the holding chamber until tested.
(ii) Extracellular field recordings. Field recordings were used to assess synaptic transmission and plasticity in the Schaffer collateral/commissural CA1 pathway. For field excitatory postsynaptic potential (fEPSP) recordings, a glass pipette was filled with the ACSF or 1 mM NaCl (3 to 5 M resistance) and placed within the striatum radiatum. For high-frequency stimulation, two bipolar tungsten electrodes (S1 and S2) were placed on opposite sides of the recording electrode along the Schaffer collateral fibers in the striatum radiatum. The test stimulation was delivered alternately through S1 and S2 once per minute. After 30 to 60 min of recording for control tetanus stimulation, three or four trains of square pulses (100 pulses at 100 Hz) were delivered with 3- to 4-min intervals through S1, while the S2 was turned off. In some cases, theta burst stimulation was also used. These two stimulation methods were compared in the previous whole-cell recordings, and no clear difference was noted. For late-phase long-lasting LTP (L-LTP), field potentials evoked by S1 and S2 were monitored in the same way as in the control for a minimum of 180 min and, in most cases, up to 300 min after the LTP induction protocol. The peak amplitude (or 30 to 70% rising slope) of all fEPSPs recorded from an individual slice were normalized to the mean peak amplitude (or slope) during the 30 min before the theta burst or high-frequency stimulation, and these normalized values were used to compared LTPs induced in various treatment groups. Field potentials were recorded with an Axon amplifier 2B (Axon Instruments, Union City, CA). Data acquisition and analysis were done off-line using P-Clamp 9 software and Origin. All data are presented as the mean ± standard error of the mean. Significance was assessed at a P value of <0.05, using Dunnett's t test. Any recordings lasting less than 3 h were excluded from the final analysis. An average of three slices/mouse and three mice/group were used for the analysis of L-LTP. A researcher blinded to the genotypes of the mice performed all recordings.
Behavioral analysis. Control and bigenic mice were assessed at 6 to 8 months of age in a blind-controlled series of behavioral tests, including (i) a Morris water maze test and (ii) a radial arm maze.
(i) Morris water maze test. A pool (diameter 140 cm) was filled with opaque water (24 ± 1°C), and mice were trained to locate first a visible platform (days 1 to 2) and then a submerged hidden platform (days 3 to 5) in two daily sessions 3.5 h apart, each consisting of three 60-s trials (10-min intertrial intervals). Mice acquired spatially encoded information with visual cues outside the maze to locate the platform. Mice that failed to find the hidden platform within 60 s were placed on the platform for 15 s. For analysis of data, the pool was divided into four quadrants. During the visible platform training, the platform was moved to a different quadrant for each session. During the hidden platform training, the platform location was kept constant for each mouse (in the center of the target quadrant). The starting point at which the mouse was placed into the water was changed for each trial. Time to reach the platform (latency), path length, and swim speed were recorded with a Noldus Instruments EthoVision video tracking system set to analyze two samples per second. Since there were no significant differences in average swim speeds between the different groups of mice during the visible platform sessions, the time required to locate the platform (latency) was used as the main measure for analysis. A 60-s probe trial (platform removed) was carried out as described in the legend.
(ii) Radial arm maze. One week before testing, animals were placed on a restricted diet of 80% to 90% of food levels so that their initial body weight decreased by a maximum of 15%. This diet was maintained throughout the testing period; however, mice were given free access to water. Mice received food reward pellets in their home cages 1 day before pretraining to become accustomed to the novel food in a familiar environment. For pretraining, each mouse was placed in the central platform of the eight-arm radial maze and allowed to explore and consume food pellets scattered throughout the entire maze for a 15-min period. During training, mice were allowed to take a pellet from each food dispenser located at the distal end of each arm. A trial was finished after the subject mouse consumed the pellet in each of the eight arms. As a mouse consumed a pellet from each arm, the next arm opened, and when the mouse entered this arm, the first arm closed. Thus, the mouse was sequentially guided through each arm of the maze. Immediately after the training, maze acquisition trials were performed with all eight arms baited with food pellets. Mice were placed on the central platform and allowed access to all eight arms for 15 min. The session was terminated immediately after all eight food pellets concealed at the end of the arms were consumed as measured by breaking a sensor beam ("head poke") or after 15 min. An "arm visit" was defined as entering the arm and breaking both sensor light beams. Mice were confined in the center platform for 2 s after each arm choice, thus reducing behaviors such as clockwise serial searching strategies. Animals were subjected to one session per day. A MedPC software program was used for both the training and testing phases. For each trial, the following were automatically recorded: (a) latency to complete the maze and retrieve all pellets, (b) number of errors, (c) choice of arms, and (d) number of different arms chosen within the first eight choices. The operator also manually recorded the number of pellets eaten by each mouse. Each of these parameters was used to detect abnormalities in the acquisition and retention of spatially encoded information. In each case, the operator was blinded to the genotype of the mice being examined. Data are expressed as mean ± standard error of the mean. Differences among means were evaluated by analysis of variance (ANOVA) and a Tukey-Kramer test. Learning curves were compared by a repeated-measures ANOVA using contrasts to assess differences between specific groups of mice. For all analyses, the null hypothesis was rejected at the 0.05 level.
| RESULTS |
|---|
|
|
|---|
B
-SR inhibitor of NF-
B action in neurons.
To explore the
relationship between NF-
B/Rel factor activation, synaptic
signaling, and higher-order cognitive function, we generated multiple
independent lines of transgenic mice expressing an HA-tagged version of
the NF-
B/Rel inhibitor, I
B
-SR. The
I
B
-SR transgene was cloned downstream of a
tetracycline transactivator (tTA)-responsive promoter (Tet-O)
facilitating regulatable expression. By breeding these mice to a second
transgenic line of mice where the prion promoter (Prp) was used to
direct tTA expression (a generous gift from Stanley Prusiner,
University of California, San Francisco), expression of the
Tet-O-I
B
-SR transgene was restricted to neurons. In
the presence of the blood-brain barrier-permeable tetracycline
analogue, doxycycline, transcription of the tTA-regulated gene is
blocked (Fig.
1A) (22). In the presence or
absence of doxycycline, bigenic
Prp-tTA/Tet-O-HA-I
B
-SR mice were both viable and
fertile. Furthermore, these mice displayed anatomically and
structurally normal gross brain morphology as indicated by Nissl and
anti-calbindin immunofluorescence staining of the hippocampal
regions (Fig.
1B).
|
B
-SR transgene was clearly detectable (designated
I
B
-SR+ or SR+),
and its expression was suppressed in the presence of doxycycline
(designated I
B
-SR or
SR) (Fig.
1C). Three independently
derived lines of FVBN/DBA bigenic mice exhibiting the tightest
regulation of transgene expression by doxycycline and control mice were
selected for further analysis (Fig.
1C, designated by
asterisks) to ensure that the observed effects were attributable to
transgene expression rather than to a positional effect related to the
site of transgene insertion. Among several tissues examined, expression
of the I
B
-SR transgene appeared confined to brain,
and within the brain, transgene expression was detected in all regions
examined, including cerebellum, cortex, thalamus, and mid-brain (Fig.
1D and E). The levels of
HA-tagged transgenic I
B
-SR protein in hippocampal
neurons isolated from I
B
-SR+ mice
proved comparable to the levels endogenous I
B
protein
observed in either I
B
-SR or
control mice (Fig. 1F). Of
note, the level of endogenous I
B
protein was lower in
I
B
-SR+ neurons due to the loss of
NF-
B/Rel action required for the auto-regulatory induction of
the I
B
gene
(65). These equivalent
levels of transgene and endogenous protein mitigate against an
artifactual gain-of-function phenotype sometimes observed when
transgenes are overexpressed in vivo.
Immunofluorescence staining
of I
B
-SR+ brain sections confirmed
I
B
-SR transgenic protein expression in neurons from
the hippocampus, cortex, medulla, hypothalamus, and Purkinje cells of
the cerebellum (data not shown). The HA-tagged I
B
-SR
protein was not detected in matched neuro-anatomical regions from
control or I
B
-SR mice. In vivo
expression of the HA-I
B
-SR gene product was not
detected in macroglia when sections were probed with both anti-HA and
anti-glial fibrillary acidic protein (GFAP) antibodies, but expression
was detectable in MAP2-positive neurons (Fig.
1G).
To confirm
functional inhibition of NF-
B in vivo following
I
B
-SR expression, we assessed both DNA binding and
induction of NF-
B target genes. Using EMSAs, we compared
KA-induced NF-
B/Rel DNA binding activity in
I
B
-SR+ mice and
I
B
-SR mice. While robust
NF-
B/Rel activation was detected in various brain regions from
I
B
-SR mice, this response was
markedly impaired in the I
B
-SR+
mice (Fig.
2A ). These KA-induced nucleoprotein complexes contained p50, p52,
c-Rel, and RelA protein species as determined by supershifting with
specific antibodies (data not shown). Primary neuronal or glial
cultures from embryonic brain tissues from
I
B
-SR+,
I
B
-SR, and control mice were
either untreated () or exposed to TNF-
or high
concentrations of KCl (22 mM) to induce membrane depolarization. In
I
B
-SR+ neurons, the activation of
NF-
B/Rel in response to either stimuli was markedly inhibited
under both basal and stimulated conditions. In contrast,
NF-
B/Rel DNA binding was evident in both unstimulated and, to
a greater extent, in stimulated in neurons from both
I
B
-SR and control mice (Fig.
2B). Consistent with
expression of I
B
-SR in neurons, but not glia,
NF-
B/Rel activation was detected in glial cultures from
I
B
-SR+ mice as well as from
I
B
-SR and control mice (Fig.
2C).
|
B/Rel-regulated target genes, specifically Fas and the p55
TNF-
receptor (Fig.
2D). RPAs revealed that
I
B
-SR expression in neurons effectively inhibited KA
induction of the Fas and p55 TNF-
receptor genes.In contrast, both genes were effectively induced by KA in both
I
B
-SR and control mice (Fig.
2E). Together these
findings demonstrate that expression of the I
B
-SR
transgene is restricted to neurons, is tightly regulated by
doxycycline, can functionally inhibit KA-induced nuclear translocation
of NF-
B/Rel factors in neurons but not in glial cells, and is
able to effectively impair the activation of various endogenous
NF-
B/Rel-inducible target
genes.
I
B
-SR is expressed in both cortical inhibitory GABAergic interneurons and hippocampal excitatory glutamatergic neurons.
To assess potential differences in
I
B
-SR expression in functionally distinct neuronal
subtypes, we probed HA-specific immunoprecipitations of lysates
prepared from primary hippocampal excitatory neurons or from cortical
inhibitory GABAergic neuronal cultures. HA-I
B
-SR
transgene expression was detected only in
I
B
-SR+ lysates and, taking into
account ß-tubulin protein input levels, expression levels of
I
B
-SR approximately seven times higher were detected
in cortical cultures enriched for GABAergic interneurons relative to
levels detected in hippocampal cultures enriched for excitatory
glutamatergic neurons (Fig.
3A). The relative levels of inhibitory GABAergic neurons and excitatory
glutamatergic neurons present in cortical cultures and hippocampal
cultures were quantitated by immunofluorescence staining using
antibodies specific for vesicular GABA transporter VGAT (GABAergic)
versus vesicular glutamate transporter VGLUT (glutamatergic),
respectively. Cortical neuronal cultures were enriched for GABAergic
interneurons (98% VGAT+ cells), whereas hippocampal
cultures primarily contained glutamatergic cells (83%
VGLUT+ cells) (Fig.
3B). Enhanced
prion-promoter driven HA-I
B
-SR expression in
GABAergic interneurons is consistent with the activity of the prion
promoter in vivo, where either the endogenous prion protein or a
Prp-enhanced green fluorescent protein transgene was robustly expressed
in these neuronal cells with little or no protein detected in glia
(5,
51).
|
B by I
B
-SR results in deceased GAD65 expression in inhibitory GABAergic interneurons.
Probing hippocampal lysates from
I
B
-SR+ mice revealed markedly
decreased levels of glutamate decarboxylase (GAD65), the rate-limiting
enzyme required for the synthesis of the inhibitory neurotransmitter,
GABA (Fig. 3C). However,
no difference in the levels of the vesicular GABA transporter protein
(VGAT) was observed in lysates from mice in all three groups, arguing
against a selective loss of these inhibitory GABAergic interneurons in
I
B
-SR+ mice (Fig.
3C). Similarly, primary
neuronal cultures isolated from
I
B
-SR+ mice expressed
significantly lower levels of GAD65 (Fig.
3D).
Consistent with
the immunoblotting results, GAD65 mRNA levels were decreased relative
to levels seen in either I
B
-SR or
control mice. Both end-point PCR and real-time PCR (Fig.
3E) analysis confirmed
lower GAD65 mRNA transcripts in GABAergic interneurons in
I
B
-SR+ mice, suggesting that the
GAD65 gene is regulated either directly or indirectly by
NF-
B/Rel. Together, these findings indicate that
NF-
B/Rel is required for expression of GAD65 in GABAergic
interneurons and suggest that NF-
B/Rel factors may regulate
inhibitory neuronal function.
Inhibition of NF-
B/Rel action by I
B
-SR expression in neurons leads to increased LTP in the hippocampus.
We next investigated the potential
impact of I
B
-SR expression in both inhibitory and
excitatory neurons on the induction of LTP following tetanus or
high-frequency stimulation. The averages of peak amplitudes of fEPSPs
(S1) from all trials collected 15 to 30 min before the induction of LTP
(100%) were used to normalize peak amplitude of fEPSPs of each
individual trial acquired over 300 min after tetanus stimulation (Fig.
4A-D). Similar recordings were obtained using theta burst high-frequency
stimulation (data not shown). While tetanus stimulation of the
Schaffer-collateral pathway induced higher fEPSP amplitude (LTP) in all
three groups, we observed significantly greater potentiation in
hippocampal slices from several
I
B
-SR+ mice (Fig.
4D). In all cases, the
enhanced S1 fEPSP lasted for a minimum of 180 min, and in most cases,
responses were recorded for 300 min, consistent with enhanced L-LTP. To
monitor basal synaptic signaling, a second stimulating electrode was
placed at the other side of the recording electrode to evoke control
fEPSPs (S2) between S1 trials. The S2 fEPSPs evoked by this
unstimulated pathway did not show any significant change after the
tetanus stimulation of the S1 pathway and remained steady for the
duration of the recording. The LTP induced in hippocampal slices from
I
B
-SR+ mice was consistently
higher than that observed in either
I
B
-SR or control mice,
(P < 0.05, Dunnett's t test) (Fig.
4D). The observed
enhancement of synaptic signaling did not appear to reflect an overall
increase in synapse numbers in I
B
-SR+ mice.
Similar levels of synapsin, synaptophysin, and complexin as well as
myelin basic protein were observed in sections or hippocampal membrane
fractions isolated from either
I
B
-SR+,
I
B
-SR or control mice. In
addition, overall neuronal and glial cell content was equivalent in
mice from all three groups as evidenced by comparable levels of the
neuronal cell marker MAP2 or the glial cell marker GFAP (data not
shown).
|
B
-SR+,
I
B
-SR, or control mice (Fig.
4E). However, using low
Mg2+/high K+ supplemented medium
to facilitate neuronal excitation
(3), robust Arc expression
was detected in cultures from
I
B
-SR+ mice but not from
I
B
-SR or control mice (Fig.
4F). Arc induction was
blocked in I
B
-SR+ cultures
following pretreatment with the NMDA (N-methyl-D-aspartate)
antagonist, AP5, but not with the AMPAR
((alpha-amino-3-hydroxy-5-methyl-4-isoxazole propionic acid receptor)
antagonist, CNQX (6-cyano-2,3-dihydroxy-7-nitro-quinoxaline) (Fig.
4F). Of note, the
induction of Arc by CNQX in all three mice lines is consistent with a
recent report in which inhibiting AMPAR activity strongly potentiates
activity-dependent Arc expression at the level of transcription by
blocking AMPAR-coupled Gi signaling
(60). Taken together,
these findings support the notion that I
B
-SR
expression in neurons may disturb the homeostatic balance between
inhibitory interneurons and excitatory neuronal functions, leading to
hyperexcitability, increased LTP, and induction of activity-dependent
target genes like arc.
Selective inhibition of NF-
B/Rel action in neurons alters cognitive behaviors.
To
explore in vivo the impact of I
B
-SR
expression in neurons on cognitive function, four groups of FVBN/DBA
genetically matched male mice at 6 to 8 months of age were evaluated in
a range of behavioral tests. Each cohort included mice from each of the
following groups: (i) nontransgenic or singly transgenic mice (control;
n = 57), (ii) bigenic mice from three independently
derived lines maintained on doxycycline from 1 month of age
(I
B
-SR; n = 63),
(iii) bigenic mice off doxycycline and expressing the
I
B
superrepressor
(I
B
-SR+; n = 91),
and (iv) bigenic mice on doxycycline in utero to suppress transgene
expression during development but subsequently switched to a
nondoxycycline diet at 1 month of age to allow transgene expression
(I
B
-SR+*; n =
29). Of note, all I
B
-SR+ mice
appeared to be significantly more active in their home cages and were
much more sensitive to handling-induced seizures.
Using the
elevated plus maze to assess anxiety levels, no differences were
detected in mice from any of the groups. This normal or unimpaired
anxiety phenotype was confirmed using the zero maze, with mice in all
groups spending equivalent amounts of time in the maze (Table
1). Interestingly, in the plus maze, both
I
B
-SR+ and
I
B
-SR+* mice consistently
exhibited increased exploratory activity as indicated by the total
distance moved in both the open arms (P < 0.01,
Tukey-Kramer test) and in the closed arms of the plus maze (P
< 0.01, Tukey-Kramer test) (Table
1).
I
B
-SR+ and
I
B
-SR+* mice also exhibited
heightened exploratory activity with more rearing events relative to
their doxycycline-treated littermates
(I
B
-SR) or control mice,
(P < 0.01) in the open-field test
(52). This increased
exploratory activity could reflect diminished inhibitory tone leading
to increased excitatory neuronal activity in the
I
B
-SR+ mice. However, direct
effects related to I
B
-SR expression in excitatory
neurons cannot be excluded.
|
B
-SR+ mice spent significantly
more time overall exploring both objects on each day, consistent with
an enhanced exploratory behavior. Examination of sensorimotor function
by rotorod testing also revealed no significant differences between
these various transgenic animals (data not
shown).
I
B
-SR+ mice exhibit enhanced performance in spatial memory tests.
In view of a recent report describing
impaired spatial learning in mice lacking p65/RelA expression and
NF-
B action in all neurons and in glial cells
(49), we evaluated
spatial memory in the I
B
-SR+,
I
B
-SR, and control mice. Using
the Morris water maze, we observed that the
I
B
-SR+ mice located both the
visible and hidden platforms in significantly less time than their
control counterparts (P < 0.01) (Fig.
5A). Swim speeds for mice in all groups were similar
(control, 17.9 ± 0.7 cm/s;
I
B
-SR+, 14.8 ± 0.3 cm/s;
I
B
-SR, 16.7 ±0.6 cm/s;
I
B
-SR+*, 16.5 ± 0.5 cm/s).
These data indicate an overall enhancement of spatial learning and
memory in I
B
-SR+ mice. There was a
significant genotype by session interaction in both phases of the test
(P = 0.0433, repeated-measures ANOVA). Interestingly,
I
B
-SR+* mice expressing the
I
B
-SR transgene after 1 month of age exhibited even
stronger acceleration of spatial learning and memory. Bigenic
I
B
-SR+ mice learned much faster
than I
B
-SR or control mice (Fig.
5A, inset), as shown by
the change in overall performance between the first and last sessions
of each test phase and by the changes in latency (per mouse) between
two subsequent sessions of the test (P < 0.05,
Tukey-Kramer test). Conversely, bigenic
I
B
-SR mice on doxycycline, which
silenced transgene expression, displayed levels of spatial learning and
memory similar to control mice.
|
B
-SR+ and
I
B
-SR mice spent significantly
more time in the target quadrant than in any other quadrant, indicating
that all mice had learned and recalled the platform location by the end
of testing (P < 0.01;, Tukey-Kramer) (data not shown).
However, when probe trials were performed at earlier times during
testing with a second cohort of
I
B
-SR and
I
B
-SR+ mice (n =
5 for each group), we observed that
I
B
-SR+ mice spent significantly
more time in the target quadrant than in any other quadrant even after
only one day of testing (for SR+, P
< 0.05; target versus any other quadrant) (Fig.
5B). In contrast, the
I
B
-SR mice failed to show any
preference for the target quadrant on day 1. On day 2, the
I
B
-SR+ mice showed an even stronger
preference for the target quadrant (for SR+,
P = 0.0051; P < 0.05 target versus
right quadrant and P < 0.01 target versus left and
opposite quadrants). While the I
B
-SR mice
exhibited a trend toward favoring the target quadrant on day 2, this
result did not reach statistical significance (P =
0.198). Even on day 3, the I
B
-SR+
mice continued to show a preference for the target quadrant,
(SR+, P < 0.05; target versus any
other quadrant). In contrast to the accelerated retrieval of spatial
memory observed in I
B
-SR+ mice,
I
B
-SR mice display a preference
for the target quadrant only on day 3 of testing
(SR, P = 0.0025;
P < 0.05 target versus right quadrant and P
< 0.01 target versus left and opposite quadrants). These
findings are consistent with the overall enhanced performance of
I
B
-SR+ mice in the Morris water
maze.
Since the Morris water maze test may involve a component of
stress relayed to exposure to water, we tested a second cohort of mice
using the radial arm maze, paralleling the study described by Meffert
et al. (49). Using time
to complete the maze (latency) as a measure of spatial learning and
memory, we observed that I
B
-SR+
mice again displayed improved spatial learning and memory relative to
either I
B
-SR or control mice
(P < 0.01) (Fig.
5C). After two pretraining
sessions, faster times were recorded for
I
B
-SR+ mice on day 1 of the maze
test and the I
B
-SR+ mice continued
to exhibit enhanced performance throughout the remainder of the test.
Additionally, using the "number of errors" in the
radial arm maze paradigm as reported by Meffert et al. for
p65/ TNFR/
mice, the I
B
-SR+ mice also
performed better than the I
B
-SR
or control mice (Fig. 5C,
inset).
To determine the relationship between maze
performance and synaptic signaling, we assessed potential correlations
between the magnitude of LTP recorded (percent over baseline) and
latency in radial arm maze-trained mice. Striking correlations between
the increase in LTP and either the time recorded (r =
0.95; P = 0.0134; n = 5) or
in errors made in the last trial (r = 0.98;
P = 0.0048; n = 5) were observed.
Correcting the maze data for potential differences in performance in
trial 1 [percent improvement measure calculated as the (performance in
the first trial performance in the last trial)/performance in
the first trial], the magnitude of the LTP recorded (percentage over
baseline) was strongly correlated with percent improvement in time to
complete the maze (r = 0.88; P =
0.0239; n = 5) and in errors made (r
= 0.81; P = 0.049; n =
5). These findings reveal a strong correlation between
improved LTP and enhanced performance in the radial arm maze. Thus,
based on these two independent tests, we suggest that the neuronal
pattern of expression of I
B
-SR in these mice results
in enhanced spatial learning and
memory.
Activity-dependent recovery of synaptic signaling and gluR1 levels in trained I
B
-SR+ mice.
In recording synaptic
signaling along the Schaffer collateral/commissural pathway, the
intensity of the electrical stimulation (input [I]) and the peak
amplitude of the fEPSPs (output [O]) evoked were used to establish an
I/O function as a measure of the basal synaptic transmission.
Strikingly, untrained I
B
-SR+ mice
exhibited significantly impaired basal synaptic transmission relative
to levels in similarly untrained control mice (Fig.
6A). In contrast, I/O functions in
I
B
-SR mice were equivalent to
levels detected in control mice (data not shown). In sharp contrast to
the impaired I/O function observed in naive mice, maze-trained
I
B
-SR+ mice displayed a completely
restored I/O function (Fig.
6B).
|
B
-SR+ mice relates to
markedly decreased GluR1 levels detected in
I
B
-SR+ mice. Immunoblot analysis
showed that levels of AMPA-type GluR1 subunits in synaptosomal membrane
preparations were significantly decreased in naive
I
B
-SR+ mice compared to untrained
I
B
-SR littermates or
nontransgenic control mice (Fig.
6C). In contrast, maze
training resulted in a much greater activity-dependent increase in
GluR1 levels in the I
B
-SR+
hippocampus than in either I
B
-SR
littermates or control mice (Fig.
6D, lane 1 versus lanes 3
and 5; note the lower levels of basal GluR1 in untrained
SR+ lysates relative to SR or
control lysates). A similar activity-dependent restoration of GAD65
levels was not observed in I
B
-SR+
mice. This activity-dependent increase in GluR1 may be a consequence of
hyperexcitation of glutamatergic neurons occurring in the context of
diminished inhibitory tone and/or altered excitatory circuits in
I
B
-SR+ mice.
Synaptic
signaling induced by behavioral training was evaluated by EMSA using
CREB and NF-
B/Rel-specific radiolabeled probes.
NF-
B/Rel DNA binding was increased in trained
I
B-SR and control mice but, consistent
with expression of I
B
-SR, was unaffected in
I
B
-SR+ mice (Fig.
6E). Of note, CREB DNA
activity was slightly increased in
I
B
-SR+ mice under both basal and
maze-trained conditions (Fig.
6E), suggesting that this
factor may be activated in response to pan-neuronal NF-
B
inhibition. While direct effects of I
B
-SR expression
on excitatory neuronal activity cannot be excluded, the
activity-dependent restoration of synaptic strength (I/O), improved
synaptic signaling (LTP and Arc levels), and enhanced cognitive
functions are consistent with heightened excitatory activity resulting
from impaired GAD65-dependent inhibitory neuronal function in
I
B
-SR+
mice.
| DISCUSSION |
|---|
|
|
|---|
B as a regulator of synaptic plasticity and memory formation.
Alterations in synaptic plasticity
reflect composite changes occurring not only in excitatory neurons but
also within inhibitory interneurons
(32-34,
67). Our findings suggest
a surprising and previously unrecognized role for the NF-
B/Rel
family of transcriptional factors as critical modulators of the
homeostatic interplay occurring between inhibitory and excitatory
neuronal function. Further, our studies reveal that NF-
B is an
important positive regulator of GAD65, an enzyme that is critical for
establishment of GABAergic interneuron-mediated inhibitory tone in
vivo.
Using the prion promoter-enhancer, we have generated a
transgenic mouse model in which a dominantly acting inhibitor of
NF-
B action is exclusively expressed in neurons. This
inhibitor, termed I
B
-SR, is strongly expressed in
GABAergic inhibitory interneurons and, to a lesser extent, in
excitatory neurons. As noted, I
B
-SR expression
results in decreased expression of GAD65 in GABAergic interneurons.
I
B
-SR expression also leads to impaired basal
synaptic signaling, likely due to decreased synaptosomal AMPAR-type
glutamate receptor (GluR1) expression, resulting in sharply impaired
I/O function in untrained or naive mice (Fig.
7). However, after these I
B
-SR+ mice
are subjected to an experience- or task-based activity (e.g., maze
training), AMPAR-type GluR1 levels are markedly increased in
synaptosomal membranes, and I/O function is completely restored. We
suspect that this training converts formerly "silent"
dendritic spines into active ones, facilitating increased neuronal
excitation (21). Enhanced
activity-dependent synaptic signaling in
I
B
-SR+ mice could reflect
increased AMPAR-mediated neuronal excitation occurring as a consequence
of diminished GAD65-derived inhibitory tone, although direct effects of
I
B
-SR expression in excitatory neurons may also
contribute to the observed phenotype. Consistent with this proposed
model, I
B
-SR+ mice exhibit
increased L-LTP and synaptic activity-dependent gene expression,
enhanced physical and exploratory activity, higher incidence of
seizures, and improved performance in various tests of spatial
learning.
|